Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 02, 2015 11:01 PM ET

Biotechnology

Company Overview of Synergy Pharmaceuticals, Inc.

Executive Profile

Douglas A. Drossman M.D.

Member of the Clinical Advisory Board, Synergy Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Douglas A. Drossman, also known as Doug, M.D. served as Scientific and Clinical Advisor of Ocera Therapeutics, Inc. Dr. Drossman is a world authority in the field of functional GI disorders. He is Professor of Medicine and Psychiatry and Co-Director of the UNC Center for Functional GI & Motility Disorders (UNC School of Medicine, Division of Gastroenterology & Hepatology). He serves as Director of Symphony Icon, Inc. Dr. Drossman is a board certified gastroenterologist ...

Corporate Headquarters

420 Lexington Avenue
New York, New York 10170

United States

Phone: 212-297-0020
Fax: 212-297-0019

Board Members Memberships

Director

Education

Master's Degree
American College of Gastroenterology

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
$500.0K
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$3.6M
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
$440.2K
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Chief Executive of Corporate Development & Finance, Executive Director, Member of Management Board and Member of Compliance Committee
Almirall, S.A.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Synergy Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.